Detalhe da pesquisa
1.
Survival update of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma in the OpACIN and OpACIN-neo trials.
Ann Oncol
; 34(4): 420-430, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36681299
2.
Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma.
Nat Med
; 27(2): 256-263, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33558721